PDA liǵation and health outcomes: A meta-analysis

Pediatrics

Volumn 133, Issue 4, 2014, Pages

  Weisz, Dany E ^a,b   More, Kiran ^b   McNamara, Patrick J ^b,c,d   Shah, Prakesh S ^e,f  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Department of Physiology ^*  (Canada)

^d HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cerebral palsy; Chronic lung disease; Cognitive impairment; Death; Mortality; Neurodevelopmental impairment; Patent ductus arteriosus; Retinopathy of prematurity

Indexed keywords

BRAIN HEMORRHAGE; CHRONIC LUNG DISEASE; COGNITIVE DEFECT; COHORT ANALYSIS; CORONARY ARTERY LIGATION; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; ECHOCARDIOGRAPHY; GESTATIONAL AGE; HUMAN; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; REVIEW; RISK ASSESSMENT; SEPSIS; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL RATE; SYSTEMATIC REVIEW; CEREBRAL PALSY; DEATH; LIGATION; META ANALYSIS; NEURODEVELOPMENTAL IMPAIRMENT; NEWBORN; TREATMENT OUTCOME;

CEREBRAL PALSY; CHRONIC LUNG DISEASE; COGNITIVE IMPAIRMENT; DEATH; MORTALITY; NEURODEVELOPMENTAL IMPAIRMENT; PATENT DUCTUS ARTERIOSUS; RETINOPATHY OF PREMATURITY;

DEVELOPMENTAL DISABILITIES; DUCTUS ARTERIOSUS, PATENT; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; LIGATION; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84898742413     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-3431     Document Type: Review

References (185)

1. Sellmer A, Bjerre JV, Schmidt MR, et al. Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3. Arch Dis Child Fetal Neonatal Ed. 2013;98(6):F505-F510.
2. Giliberti P, De Leonibus C, Giordano L, Giliberti P. The physiopathology of the patent ductus arteriosus. J Matern Fetal Neonatal Med. 2009;22(suppl 3):6-9
3. Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics. 2010;125(5):1020-1030
4. Shimada S, Kasai T, Hoshi A, Murata A, Chida S. Cardiocirculatory effects of patent ductus arteriosus in extremely low-birth-weight infants with respiratory distress syndrome. Pediatr Int. 2003;45(3): 255-262
5. Sehgal A, Coombs P, Tan K, McNamara PJ. Spectral Doppler waveforms in systemic arteries and physiological significance of a patent ductus arteriosus. J Perinatol. 2011;31(3):150-156
6. Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D. Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics. 2011;128(6). Available at: www.pediatrics.org/cgi/content/full/128/6/e1618
7. Malviya MN, Ohlsson A, Shah SS. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2013;3:CD003951
8. Mirea L, Sankaran K, Seshia M, et al Canadian Neonatal Network. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias. J Pediatr. 2012; 161(4):689-694, e1
9. Clyman R, Cassady G, Kirklin JK, Collins M, Philips JB III. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr. 2009;154(6): 873-876
10. Madan JC, Kendrick D, Hagadorn JI, Frantz ID III; National Institute of Child Health and Human Development Neonatal Research Network. Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics. 2009;123(2):674-681
11. Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A; Trial of Indomethacin Prophylaxis in Preterms Investigators. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr. 2007;150(3):229-234, e1
12. Chorne N, Leonard C, Piecuch R, Clyman RI. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics. 2007;119(6):1165-1174
13. Clyman RI. Surgical ligation of the patent ductus arteriosus: treatment or morbidity? J Pediatr. 2012;161(4):583-584
14. Clyman RI, Couto J, Murphy GM. Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all? Semin Perinatol. 2012;36(2):123-129
15. Noori S. Patent ductus arteriosus in the preterm infant: to treat or not to treat? J Perinatol. 2010;30(suppl):S31-S37
16. Noori S. Pros and cons of patent ductus arteriosus ligation: hemodynamic changes and other morbidities after patent ductus arteriosus ligation. Semin Perinatol. 2012; 36(2):139-145
17. Jhaveri N, Moon-Grady A, Clyman RI. Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatment. J Pediatr. 2010; 157(3):381-387, e1
18. Wickremasinghe AC, Rogers EE, Piecuch RE, et al. Neurodevelopmental outcomes following two different treatment approaches (early ligation and selective ligation) for patent ductus arteriosus. J Pediatr. 2012;161(6):1065-1072
19. Kaempf JW, Wu YX, Kaempf AJ, Kaempf AM, Wang L, Grunkemeier G. What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants? J Perinatol. 2012;32(5):344-348
20. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6 :e1000097
21. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988;82(4):527-532
22. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123(7):991-999
23. Bayley N. Bayley Scales of Infant Development: Manual. 2nd ed. San Antonio, TX: The Psychological Corp, Harcourt Brace & Co; 1993
24. Bayley N. Bayley Scales of Infant and Toddler Development. 3rd ed. San Antonio, TX: Harcourt Assessment; 2006
25. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39(4):214-223
26. Higgins JP, Altman DG, Gøtzsche PC, et al Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343: d5928
27. Newcastle-Ottawa Scale. 2013. Available at: www.ohri.ca/programs/ clinical-epidemiology/nosgen.pdf. Accessed May 31, 2013
28. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration. Version 5.1.0. 2011. Available at: www.cochrane-handbook.org. Accessed June 21, 2013
29. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558
30. Jawa G, Husein M, Macrae D, Coughlin K, Seabrook J, da Silva O. Short and long term outcomes following PDA ligation in VLBW infants. Paediatr Child Health. 2013; 18(6)(suppl A):49A
31. Tsui I, Ebani E, Rosenberg JB, Lin J, Angert RM, Mian U. Patent ductus arteriosus and indomethacin treatment as independent risk factors for plus disease in retinopathy of prematurity. J Pediatr Ophthalmol Strabismus. 2013;50(2):88-92
32. Youn Y, Lee JY, Lee JH, Kim SY, Sung IK, Lee JY. Impact of patient selection on outcomes of PDA in very low birth weight infants. Early Hum Dev. 2013;89(3):175-179
33. Moore GP, Lawrence SL, Maharajh G, et al. Therapeutic strategies, including a high surgical ligation rate, for patent ductus arteriosus closure in extremely premature infants in a North American centre. Paediatr Child Health. 2012;17(4):e26-e31
34. Hsu DM, Li L, Tseng CH, Kelley-Quon LI, Shew SB. Analysis of defined mortality for patent ductus arteriosus: implications for measuring quality in neonatal surgical care. J Am Coll Surg. 2012;215(3):S104
35. Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr. 1978;93(4):647-651
36. Merritt TA, DiSessa TG, Feldman BH, Kirkpatrick SE, Gluck L, Friedman WF. Closure of the patent ductus arteriosus with ligation and indomethacin: a consecutive experience. J Pediatr. 1978;93(4):639-646
37. Merritt TA, White CL, Jacob J, et al. Patent ductus arteriosus treated with ligation or indomethacin: a follow-up study. J Pediatr. 1979;95(4):588-591
38. Cats BP, Van Ertbruggen I, Gerards LJ. Patent ductus arteriosus in premature infants [in Dutch]. Tijdschr Kindergeneeskd. 1980;48(4):107-111
39. Mikhail M, Lee W, Toews W, et al. Surgical and medical experience with 734 premature infants with patient ductus arteriosus. J Thorac Cardiovasc Surg. 1982;83 :349-357
40. Zerella JT, Spies RJ, Deaver DC III, Dailry WJ, Haple DC, Trump DS. Indomethacin versus immediate ligation in the treatment of 82 newborns with patent ductus arteriosus. J Pediatr Surg. 1983;18(6): 835-841
41. Wagner HR, Ellison RC, Zierler S, et al. Surgical closure of patent ductus arteriosus in 268 preterm infants. J Thorac Cardiovasc Surg. 1984;87(6):870-875
42. Castañón M, Mortera C, Claret P, Moreu C, Claret I. Surgical treatment of ductus arteriosus in premature infants [in Spanish]. Cir Pediatr. 1988;1(4):158-160
43. Trus T, Winthrop AL, Pipe S, Shah J, Langer JC, Lau GY. Optimal management of patent ductus arteriosus in the neonate weighing less than 800 g. J Pediatr Surg. 1993; 28(9):1137-1139
44. Perez CA, Bustorff-Silva JM, Villasenor E, Fonkalsrud EW, Atkinson JB. Surgical ligation of patent ductus arteriosus in very low birth weight infants: is it safe? Am Surg. 1998;64(10):1007-1009
45. Koehne PS, Bein G, Alexi-Meskhishvili V, Weng Y, Bührer C, Obladen M. Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment. J Perinat Med. 2001;29(4):327-334
46. Niinikoski H, Alanen M, Parvinen T, Aantaa R, Ekblad H, Kero P. Surgical closure of patent ductus arteriosus in very-lowbirth-weight infants. Pediatr Surg Int. 2001;17(5-6):338-341
47. Little DC, Pratt TC, Blalock SE, Krauss DR, Cooney DR, Custer MD. Patent ductus arteriosus in micropreemies and full-term infants: the relative merits of surgical ligation versus indomethacin treatment. J Pediatr Surg. 2003;38(3):492-496
48. O'Donovan DJ, Baetiong A, Adams K, et al. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus. J Perinatol. 2003;23(4):286-290
49. Hwang HK, Chen MR, Wu SJ, et al. Surgical ligation of patent ductus arteriosus in extremely low birth weight premature neonates. Acta Cardiol Sinica. 2005;21(1): 30-34
50. Lee LCL, Tillett A, Tulloh R, Yates R, Kelsall W. Outcome following patent ductus arteriosus ligation in premature infants: a retrospective cohort analysis. BMC Pediatr. 2006;6:15
51. Pelausa E, Kovacs L, Papageorgiou A. Surgical Ligation of PDA Has an Impact on CLD and Other Significant Morbidities. E-PAS; 2006:5534.197
52. Laughon M, Bose C, Clark R. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes. J Perinatol. 2007;27(3):164-170
53. Qureshi M, Al-Sufayan F, Kwiatkowsky K, Moddemann D, Baier RJ, Seshia M. Respiratory Outcome of VLBW Infants After PDA Treatment by Ligation or Indomethacin. E-PAS; 2008:63532
54. Sato RY, Beuning CM, Hall DG, Woods RK. Outcomes After Patent Ductus Arteriosus (PDA): Ligation With and Without Prior Indomethacin Exposure. E-PAS; 2008: 635842.5
55. Tschuppert S, Doell C, Arlettaz-Mieth R, et al. The effect of ductal diameter on surgical and medical closure of patent ductus arteriosus in preterm neonates: size matters. J Thorac Cardiovasc Surg. 2008;135(1):78-82
56. Alexander F, Chiu L, Kroh M, Hammel J, Moore J. Analysis of outcome in 298 extremely low-birth-weight infants with patent ductus arteriosus. J Pediatr Surg. 2009;44(1):112-117
57. Ko YC, Chang CI, Chiu IS, Chen YS, Huang SC, Hsieh WS. Surgical ligation of patent ductus arteriosus in very-low-birth-weight premature infants in the neonatal intensive care unit. J Formos Med Assoc. 2009;108(1):69-71
58. Qureshi M, Al-Sufayan F, Kwiatkowski K, Moddemann D, Seshia M, Baier RJ. Is PDA Ligation Responsible for the Adverse Outcome in Very Low Birthweight (VLBW) Infants With PDA? E-PAS; 2009:476
59. Vida VL, Lago P, Salvatori S, et al. Is there an optimal timing for surgical ligation of patent ductus arteriosus in preterm infants? Ann Thorac Surg. 2009;87(5): 1509-1515; discussion 1515-1516
60. Chiruvolu A, McKinley PS, Whitfield JM. Surgical Ductal Ligation and Adverse Outcomes: A Single-Center Perspective. E-PAS; 2010:479
61. Lopes R, Synnes AR, Sherlock R. Patent ductus arteriosus treatments and neurodevelopment outcome at 18 months. Paediatr Child Health. 2010;15(Suppl A): 39A-40A 62. Natarajan G, Chawla S, Aggarwal S. Shortterm outcomes of patent ductus arteriosus ligation in preterm neonates: reason for concernAm J Perinatol. 2010;27(6): 431-437
62. Rheinlaender C, Helfenstein D, Pees C, et al. Neurodevelopmental outcome after COX inhibitor treatment for patent ductus arteriosus. Early Hum Dev. 2010;86(2): 87-92
63. Pelausa E, Kovacs L, Papageorgiou A. Are Growth and Development Worse for Very Premature Infants With PDA LigationE-PAS; 2011:32
64. Adrouche-Amrani L, Green RS, Gluck KM, Lin J. Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants. BMC Pediatr. 2012;12:10
65. Heuchan AM, Hunter L, Young D. Outcomes following the surgical ligation of the patent ductus arteriosus in premature infants in Scotland. Arch Dis Child Fetal Neonatal Ed. 2012;97(1):F39-F44
66. Strauss A, Franklin C, Beharry K. Incidence of Severe ROP in Preterm Infants Requiring PDA Ligation. E-PAS; 2011:652
67. Ambadwar P, Bird TM, El-Hassan N, et al. Variation in first line treatment strategies for patent ductus arteriosus among large children's hospitals. J Investig Med. 2011; 59(2):518
68. Andrade H, Loureiro C, Tiago J, et al. Patent ductus arteriosus -neonatal intensive care unit registry. Rev Port Cardiol. 2008;27 (7-8):877-885
69. Armangil D, Yurdakok M, Karagoz T, et al. The retrospective analysis of premature infants with patent ductus arteriosus ligation in the neonatal intensive care unit. [in Turkish] Cocuk Sagligi Hast Derg. 2008;51(4):187-192
70. Aydogdu A, Cakmak BC, Bakiler AR, Engur D, Turkmen MK. Evaluation of patent ductus arteriosus cases in a neonatal intensive care unit. Early Hum Dev. 2010;86 (Supplement):S40
71. Beani L, Moscardini AC, Souza AS, et al. Late pulmonary tomography assessment in premature infants with bronchopulmonary dysplasia submitted to patent ductus arteriosus management. Braz J Card Surg. 2007;22(4):400-406
72. Beitzke A, Trop M, Rigler B. Surgical management of patent ductus arteriosus in premature infants with respiratory distress syndrome. Indications, procedure, outcome. Pediatr Cardiol. 1983;4(suppl 2): 61-64
73. Blesa Sánchez E, Moreno Hurtado C, Enríquez Zarabozo E, Ayuso Velasco R. Surgical closure of ductus arteriosus in the extreme or very extreme preterm infant. [in Spanish] Cir Pediatr. 2010;23(3): 137-140
74. Brown ER. Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. J Pediatr. 1979;95(5 pt 2):865-866
75. Canarelli JP, Poulain H, Clamadieu C, Ricard J, Maingourd Y, Quintard JM. Ligation of the patent ductus arteriosus in premature infants -indications and procedures. Eur J Pediatr Surg. 1993;3(1):3-5
76. Cassady G, Crouse DT, Kirklin JW, et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med. 1989;320(23): 1511-1516
77. Cho J, Yoon YH, Kim JT, et al. Patent ductus arteriosus closure in prematurities weighing less than 1 kg by subaxillary mini-thoracotomy. J Korean Med Sci. 2010; 25(1):24-27
78. Dasmahapatra HK, Sethia B, Pollock JC. Surgical closure of persistent ductus arteriosus (PDA) in infants before 30 weeks gestation. J Cardiovasc Surg (Torino). 1986;27(6):675-678
79. Edmunds LH Jr., Gregory GA, Heymann MA, Kitterman JA, Rudolph AM, Tooley WH. Surgical closure of the ductus arteriosus in premature infants. Circulation. 1973;48 :856-863
80. Fendler W, Bernas S, Jarosik K, Piotrowski A. Is it possible to predict the success of pharmacological closure of persistent ductus arteriosus in prematurely born neonates? [in Polish]. Anestezjol Intens Ter. 2008;40(3):156-161
81. Galletti S, Cosentino A, Malavolti A, Macthey E, Faldella G. Surgical treatment of patent ductus arteriosus in preterm infants. ten-year experience with ligation in the newborn intensive care unit. Arch Dis Child. 2012;97(Suppl 2):A324
82. Gay JH, Daily WJ, Meyer BH, Trump DS, Cloud DT, Molthan ME. Ligation of the patent ductus arteriosus in premature infants: report of 45 cases. J Pediatr Surg. 1973;8(5):677-683
83. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr. 1983; 102(6):895-906
84. Goldberg SJ, Allen HD, Sahn DJ. Echocardiographic detection and management of patent ductus arteriosus in neonates with respiratory distress syndrome: a two-and one-half year prospective study. J Clin Ultrasound. 1977;5(3):161-169
85. Gómez R, Moreno F, Burgueros M, Sanchez PA, Quero J, Alvarez F. Management of patent ductus arteriosus in preterm babies. Ann Thorac Surg. 1980;29(5):459-463
86. Grosfeld JL, Chaet M, Molinari F, et al. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg. 1996;224(3):350-355; discussion 355-357
87. Halliday HL, Hirata T, Brady JP. Indomethacin therapy for large patent ductus arteriosus in the very low birth weight infant: results and complications. Pediatrics. 1979;64(2):154-159
88. Hsiao CC, Wung JT, Tsao LY, Chang WC. Early or late surgical ligation of medical refractory patent ductus arteriosus in premature infants. J Formos Med Assoc. 2009;108(1):72-77
89. Hubbard C, Rucker RW, Realyvasquez F, et al. Ligation of the patent ductus arteriosus in newborn respiratory failure. J Pediatr Surg. 1986;21(1):3-5
90. Hutchings K, Vasquez A, Price D, Cameron BH, Awan S, Miller GG. Outcomes following neonatal patent ductus arteriosus ligation done by pediatric surgeons: a retrospective cohort analysis. J Pediatr Surg. 2013;48(5):915-918
91. Jaillard S, Larrue B, Rakza T, Magnenant E, Warembourg H, Storme L. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants. Ann Thorac Surg. 2006;81(1):231-234
92. Kilman JW, Kakos GS, Williams TE Jr., Craenen J, Hosier DM. Ligation of patent ductus arteriosus for persistent respiratory distress syndrome in premature infants. J Pediatr Surg. 1974;9(3):277-281
93. Kitterman JA, Edmunds LH Jr., Gregory GA, Heymann MA, Tooley WH, Rudolph AM. Patent ducts arteriosus in premature infants. Incidence, relation to pulmonary disease and management. N Engl J Med. 1972;287(10):473-477
94. Korbmacher B, Lemburg S, Zimmermann N, et al. Management of the persistent ductus arteriosus in infants of very low birth weight: early and long-term results. Interact Cardiovasc Thorac Surg. 2004;3 :460-464
95. Kumar R, Podugu L, Rasiah SV. Surgical ligation of patent ductus arteriosus in preterms less than 30 weeks gestation in a tertiary neonatal unit. Arch Dis Child. 2012;97(Suppl 2):A331
96. Lee GY, Sohn YB, Kim MJ, et al. Outcome following surgical closure of patent ductus arteriosus in very low birth weight infants in neonatal intensive care unit. Yonsei Med J. 2008;49(2):265-271
97. Lelong Tissier MC, Benoit A, Dehan M, Vial M, Ropert JC, Dupic Y. Conservative management of patent ductus arteriosus in preterm infants. Intensive Care Med. 1979; 5(1):33-36
98. Lin CT, Liu WH, Cheng BC, Wang LY, Chen TJ. Surgical closure of patent ductus arteriosus in preterm infants at neonatal intensive care unit. Acta Paediatr Taiwan. 2003;44(5):287-291
99. Locali RF, Matsuoka PK, Gabriel EA, et al. Patent ductus arteriosus treatment in the premature newborn: clinical and surgical analysis. Arq Bras Cardiol. 2008;90(5): 316-319
100. Mallya P, Sundaram J, Gupta S. Early targeted closure of patent ductus arteriosus in extreme preterm babies reduces bronchopulmonary dysplasia. Arch Dis Child. 2012;97(Suppl 2):A94
101. Mandhan P, Brown S, Kukkady A, Samarakkody U. Surgical closure of patent ductus arteriosus in preterm low birth weight infants. Congenit Heart Dis. 2009;4(1):34-37
102. Margaryan R, Arcieri L, Murzi B. Surgical closure of PDA in low-weight premature infants. J Matern Fetal Neonatal Med. 2009;22(suppl 3):81-84
103. Mavroudis C, Cook LN, Fleischaker JW, et al. Management of patent ductus arteriosus in the premature infant: indomethacin versus ligation. Ann Thorac Surg. 1983;36(5):561-566
104. Merritt TA, Harris JP, Roghmann K, et al. Early closure of the patent ductus arteriosus in very low-birth-weight infants: a controlled trial. J Pediatr. 1981;99(2): 281-286
105. Mouzinho AI, Rosenfeld CR, Risser R. Symptomatic patent ductus arteriosus in very-low-birth-weight infants: 1987-1989. Early Hum Dev. 1991;27(1-2):65-77
106. Nagle MG, Peyton MD, Harrison LH Jr., Elkins RC. Ligation of patent ductus arteriosus in very low birth weight infants. Am J Surg. 1981;142(6):681-686
107. Naik-Mathuria B, Chang S, Fitch ME, et al. Patent ductus arteriosus ligation in neonates: preoperative predictors of poor postoperative outcomes. J Pediatr Surg. 2008;43(6):1100-1105
108. Nair UR, King H, Walker DR. Surgical ligation of the patent ductus arteriosus in low birth weight pre-term infants: a review of 67 consecutive cases. J Cardiovasc Surg (Torino). 1985;26(6):577-580
109. Nelson RJ, Thibeault DW, Emmanouilides GC, Lippmann M. Improving the results of ligation of patent ductus arteriosus in small preterm infants. J Thorac Cardiovasc Surg. 1976;71(2):169-178
110. Obeyesekere HI, Pankhurst S, Yu VY. Pharmacological closure of ductus arteriosus in preterm infants using indomethacin. Arch Dis Child. 1980;55(4): 271-276
111. Ochoa-Ramírez E, Puente-Ledezma JF, Hinojosa-Pérez JO, Cervantes F. Surgical treatment of the ductus arteriosus in premature infants [in Spanish]. Gac Med Mex. 1983;119(7):295-299
112. Palder SB, Schwartz MZ, Tyson KR, Marr CC. Management of patent ductus arteriosus: a comparison of operative v pharmacologic treatment. J Pediatr Surg. 1987;22(12):1171-1174
113. Palder SB, Schwartz MZ, Tyson KR, Marr CC. Association of closure of patent ductus arteriosus and development of necrotizing enterocolitis. J Pediatr Surg. 1988;23(5):422-423
114. Peckham GJ, Miettinen OS, Ellison RC, et al. Clinical course to 1 year of age in premature infants with patent ductus arteriosus: results of a multicenter randomized trial of indomethacin. J Pediatr. 1984;105 :460-464:285-291
115. Popat H, Kapoor V, Travadi J. Patent ductus arteriosus in infants, 29 weeks gestation -outcomes and factors affecting closure. Indian Pediatr. 2012;49(8):615-620
116. Purohit DM, Levkoff AH, Taylor AB. Indomethacin closure of symptomatic patent ductus arteriosus (PDA) refractory to medical management. Clin Res. 1978;26(1):68A
117. Raval MV, Laughon MM, Bose CL, Phillips JD. Patent ductus arteriosus ligation in premature infants: who really benefits, and at what cost? J Pediatr Surg. 2007;42 :69-75
118. Robie DK, Waltrip T, Garcia-Prats JA, Pokorny WJ, Jaksic T. Is surgical ligation of a patent ductus arteriosus the preferred initial approach for the neonate with extremely low birth weight? J Pediatr Surg. 1996;31(8):1134-1137
119. Sangem M, Asthana S, Amin S. Multiple courses of indomethacin and neonatal outcomes in premature infants. Pediatr Cardiol. 2008;29(5):878-884
120. Shum B, Doyle LW, Rogerson S. The natural history of patent ductus arteriosus (PDA) in infants, 32 weeks' gestation. J Paediatr Child Health. 2011;47(Suppl 1):106
121. Singer H, Deeg KH, Richter K, Bundscherer FJ, Rein JG. Surgical treatment of patent ductus arteriosus Botalli in the premature infant. Indications and results of treatment [in German]. Monatsschr Kinde rheilkd. 1986;134(7):480-484
122. Sivakumar S, Lee L, Tillett A, Wells F, Dunning J, Kelsall AW. Outcome of ligation of the persistently patent arterial duct in neonates as performed by an outreach surgical team. Cardiol Young. 2007;17(5): 541-544
123. Sørensen CM, Steensberg JN, Greisen G. Surgical ligation of patent ductus arteriosus in premature infants. Dan Med Bull. 2010;57(6):A4160
124. Strange MJ, Myers G, Kirklin JK, et al. Surgical closure of patent ductus arteriosus does not increase the risk of intraventricular hemorrhage in the preterm infant. J Pediatr. 1985;107(4):602-604
125. van de Bor M, Verloove-Vanhorick SP, Brand R, Ruys JH. Patent ductus arteriosus in a cohort of 1338 preterm infants: a collaborative study. Paediatr Perinat Epidemiol. 1988;2(4):328-336
126. Wong C, Mak M, Shivananda S, et al Canadian Neonatal Network. Outcomes of neonatal patent ductus arteriosus ligation in Canadian neonatal units with and without pediatric cardiac surgery programs. J Pediatr Surg. 2013;48(5):909-914
127. Edmunds LH Jr. Operation or indomethacin for the premature ductus. Ann Thorac Surg. 1978;26(6):586-589
128. Fanos V, Guimarâes H. Present and future of European neonatology: focus on patent ductus arteriosus. J Matern Fetal Neonatal Med. 2009;22(suppl 3):1-2
129. Huddleston KR. Patent ductus arteriosus ligation: performing surgery outside the operating room. AORN J. 1991;53(1):69-71, 74-80
130. Knight DB. Patent ductus arteriosus: how important to which babies? Early Hum Dev. 1992;29(1-3):287-292
131. Sekar KC. Protective strategies to prevent patent ductus arteriosus. Chin Med J (Engl). 2010;123(20):2914-2918
132. Friedman WF. Pharmacologic treatment of patent ductus arteriosus. Adv Cardiol. 1979;26:65-75
133. Mirea L, Shah PS, Allen AC, et al. Surgical ligation of patent ductus arteriosus and mortality/morbidity in preterm infants: regression and propensity score analyses adjusting for treatment selection bias. Am J Epidemiol. 2011;173:S217
134. Shah P, Mirea A, Sankaran K, et al. PDA treatment and mortality/morbidity: Regression and propensity score based analyses after adjustment for treatment selection bias. Paediatr Child Health. 2011; 16(Suppl):9A
135. Tapia-Rombo CA, Calvo-Rangel KM, Saucedo-Zavala VJ, Mora-Fol JR, Santiago-Romo JE. Final outcome of preterm neonates with and without surgical treatment of patent ductus arteriosus [in Spanish]. Gac Med Mex. 2008;144(2):111-120
136. Ekici F, Atasay B, Günlemez A, et al. Management of patent ductus arteriosus in preterm infants [in Turkish]. Anadolu Kardiyol Derg. 2006;6(1):28-33
137. Hurtado del Rio D, Holden Barker AM, Pezzotti MA, et al. Management of persistent ductus arteriosus in the newborn with respiratory insufficiency [in Spanish]. Arch Inst Cardiol Mex. 1979;49(4):662-672
138. Jeon JH, Namgung R, Park MS, Park KI, Lee C. Risk of Bronchopulmonary Dysplasia (BPD) Is Increased After Surgical Ligation of Ductus Arteriosus in Preterm Infants. Pediatric Academic Societies; 2008
139. Merritt TA, White CL, Coen RW, Friedman WF, Gluck L, Rosenberg M. Preschool assessment of infants with a patent ductus arteriosus: comparison of ligation and indomethacin therapy. Am J Dis Child. 1982;136(6):507-512
140. Murphy DA, Outerbridge E, Stern L, Karn GM, Jegier W, Rosales J. Management of premature infants with patent ductus arteriosus. J Thorac Cardiovasc Surg. 1974;67(2):221-228
141. Segura-Roldán MA, Pérez de Fernández I, Hurtado del Río D, et al. Surgical closure of the ductus arteriosus in premature newborn infants. 5 years' experience [in Spanish]. Bol Med Hosp Infant Mex. 1982; 39(8):544-549
142. Sterniste W, Fürnkranz H. Indomethacin or ligation in the treatment of persistent ductus arteriosus: a report of clinical experiences. [in German] Padiatr Padol. 1989;24(2):153-159
143. Storch HH, Saggau W, Graf K, Ulmer H, Schmitz W. Indications for ligation of ductus arteriosus Botalli persistens in premature infants. [in German] Langenbecks Arch Surg. 1986;369:355-359
144. Neal WA, Bessinger FB Jr., Hunt CE, Lucas RV Jr. Patent ductus arteriosus complicating respiratory distress syndrome. J Pediatr. 1975;86(1):127-132
145. Lodha A, Newman JE, Creighton DE, et al. Does surgical ligation of patent ductus arteriosus impact language, voice, behavioral & cognitive outcomes at 36
146. Benjamin JR, Smith PB, Cotten CM, Jaggers J, Goldstein RF, Malcolm WF. Longterm morbidities associated with vocal cord paralysis after surgical closure of a patent ductus arteriosus in extremely low birth weight infants. J Perinatol. 2010; 30(6):408-413
147. Clement WA, El-Hakim H, Phillipos EZ, Coté JJ. Unilateral vocal cord paralysis following patent ductus arteriosus ligation in extremely low-birth-weight infants. Arch Otolaryngol Head Neck Surg. 2008;134(1): 28-33
148. Rukholm G, Farrokhyar F, Reid D. Vocal cord paralysis post patent ductus arteriosus ligation surgery: risks and co-morbidities. Int J Pediatr Otorhinolaryngol. 2012;76(11):1637-1641
149. Flick RP, Katusic SK, Colligan RC, et al. Cognitive and behavioral outcomes after early exposure to anesthesia and surgery. Pediatrics. 2011;128(5). Available at: www.pediatrics.org/cgi/content/full/128/5/e1053
150. Ing C, DiMaggio C, Whitehouse A, et al. Long-term differences in language and cognitive function after childhood exposure to anesthesia. Pediatrics. 2012;130 ). Available at: www.pediatrics.org/cgi/content/full/130/3/e476
151. El-Khuffash AF, Jain A, Dragulescu A, McNamara PJ, Mertens L. Acute changes in myocardial systolic function in preterm infants undergoing patent ductus arteriosus ligation: a tissue Doppler and myocardial deformation study. J Am Soc Echocardiogr. 2012;25(10):1058-1067
152. El-Khuffash AF, Jain A, McNamara PJ. Ligation of the patent ductus arteriosus in preterm infants: understanding the physiology. J Pediatr. 2013;162(6):1100-1106
153. El-Khuffash AF, McNamara PJ. The patent ductus arteriosus ligation decision. J Pediatr. 2011;158(6):1037-1038; author reply 1038-1039
154. Jain A, Sahni M, El-Khuffash A, Khadawardi E, Sehgal A, McNamara PJ. Use of targeted neonatal echocardiography to prevent postoperative cardiorespiratory instability after patent ductus arteriosus ligation. J Pediatr. 2012;160(4):584-589, e1
155. Sehgal A, Francis JV, James A, McNamara PJ. Patent ductus arteriosus ligation and post-operative hemodynamic instability: case report and framework for enhanced neonatal care. Indian J Pediatr. 2010;77(8): 905-907
156. Sehgal A, McNamara PJ. Coronary artery perfusion and myocardial performance after patent ductus arteriosus ligation. J Thorac Cardiovasc Surg. 2012;143(6): 1271-1278
157. McNamara PJ, Stewart L, Shivananda SP, Stephens D, Sehgal A. Patent ductus arteriosus ligation is associated with impaired left ventricular systolic performance in premature infants weighing less than 1000 g. J Thorac Cardiovasc Surg. 2010;140(1):150-157
158. Dammann O, Naples M, Bednarek F, et al ELGAN Study Investigators. SNAP-II and SNAPPE-II and the risk of structural and functional brain disorders in extremely low gestational age newborns: the ELGAN study. Neonatology. 2010;97(2):71-82
159. Mattia FR, deRegnier RA. Chronic physiologic instability is associated with neurodevelopmental morbidity at one and two years in extremely premature infants. Pediatrics. 1998;102(3). Available at: www.pediatrics.org/cgi/content/ full/102/3/e35
160. Brouwer A, Groenendaal F, van Haastert IL, Rademaker K, Hanlo P, de Vries L. Neurodevelopmental outcome of preterm infants with severe intraventricular hemorrhage and therapy for post-hemorrhagic ventricular dilatation. J Pediatr. 2008;152(5):648-654
161. Srinivasakumar P, Limbrick D, Munro R, et al. Posthemorrhagic ventricular dilatation -impact on early neurodevelopmental outcome. Am J Perinatol. 2013;30(3):207-214
162. van Zanten SA, de Haan TR, Ursum J, van Sonderen L. Neurodevelopmental outcome of post-hemorrhagic ventricular dilatation at 12 and 24 months corrected age with high-threshold therapy. Eur J Paediatr Neurol. 2011;15(6):487-492
163. Vohr BR, Allan WC, Westerveld M, et al. School-age outcomes of very low birth weight infants in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics. 2003; 111(4 pt 1). Available at: www.pediatrics.org/cgi/ content/full/111/4/e340
164. Klebermass-Schrehof K, Czaba C, Olischar M, et al. Impact of low-grade intraventricular hemorrhage on long-term neurodevelopmental outcome in preterm infants. Childs Nerv Syst. 2012;28(12): 2085-2092
165. Kadri H, Mawla AA, Kazah J. The incidence, timing, and predisposing
166. Schulzke SM, Deshpande GC, Patole SK. Neurodevelopmental outcomes of very low-birth-weight infants with necrotizing enterocolitis: a systematic review of observational studies. Arch Pediatr Adolesc Med. 2007;161(6):583-590
167. Kuint J, Barak M, Morag I, Maayan-Metzger A. Early treated hypotension and outcome in very low birth weight infants. Neonatology. 2009;95(4):311-316
168. Al Tawil KI, El Mahdy HS, Al Rifai MT, Tamim HM, Ahmed IA, Al Saif SA. Risk factors for isolated periventricular leukomalacia. Pediatr Neurol. 2012;46(3):149-153
169. Dammann O, Allred EN, Kuban KC, et al Developmental Epidemiology Network. Systemic hypotension and white-matter damage in preterm infants. Dev Med Child Neurol. 2002;44(2):82-90
170. Hall RW, Kronsberg SS, Barton BA, Kaiser JR, Anand KJS; NEOPAIN Trial Investigators Group. Morphine, hypotension, and adverse outcomes among preterm neonates: who's to blame? Secondary results from the NEOPAIN trial. Pediatrics. 2005;115(5): 1351-1359
171. Chau V, Brant R, Poskitt KJ, Tam EW, Synnes A, Miller SP. Postnatal infection is associated with widespread abnormalities of brain development in premature newborns. Pediatr Res. 2012;71(3):274-279
172. Schlapbach LJ, Aebischer M, Adams M, et al Swiss Neonatal Network and Followup Group. Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants. Pediatrics. 2011;128(2). Available at: www.pediatrics.org/cgi/content/full/128/2/e348
173. Bonnard A, Zamakhshary M, Ein S, Moore A, Kim PC. The use of the score for neonatal acute physiology-perinatal extension (SNAPPE II) in perforated necrotizing enterocolitis: could it guide therapy in newborns less than 1500 g? J Pediatr Surg. 2008;43(6):1170-1174
174. Sonntag J, Grimmer I, Scholz T, Metze B, Wit J, Obladen M. Growth and neurodevelopmental outcome of very low birthweight infants with necrotizing enterocolitis. Acta Paediatr. 2000;89(5):528-532
175. Brooks JM, Travadi JN, Patole SK, Doherty DA, Simmer K. Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed. 2005;90(3):F235-F239
176. Noori S, McCoy M, Friedlich P, et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics. 2009;123(1). Available at: www.pediatrics.org/cgi/content/full/123/1/e138
177. Waleh N, McCurnin DC, Yoder BA, Shaul PW, Clyman RI. Patent ductus arteriosus ligation alters pulmonary gene expression in preterm baboons. Pediatr Res. 2011;69 :212-216
178. Chang LY, McCurnin D, Yoder B, Shaul PW, Clyman RI. Ductus arteriosus ligation and alveolar growth in preterm baboons with a patent ductus arteriosus. Pediatr Res. 2008;63(3):299-302
179. Morrow WR, Taylor AF, Kinsella JP, Lally KP, Gerstmann DR, deLemos RA. Effect of ductal patency on organ blood flow and pulmonary function in the preterm baboon with hyaline membrane disease. Crit Care Med. 1995;23(1):179-186
180. Van Marter LJ, Kuban KC, Allred E, et al ELGAN Study Investigators. Does bronchopulmonary dysplasia contribute to the occurrence of cerebral palsy among infants born before 28 weeks of gestationArch Dis Child Fetal Neonatal Ed. 2011;96(1):F20-F29
181. Laughon M, O'Shea MT, Allred EN, et al ELGAN Study Investigators. Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation. Pediatrics. 2009;124(2): 637-648
182. Daniels SR. Could PDA ligation be a course of bronchopulmonary dysplasiaJ Pediatr. 2009;154(6):A2
183. Hentschel J, Berger TM, Tschopp A, Müller M, Adams M, Bucher HU; Swiss Neonatal Network. Population-based study of bronchopulmonary dysplasia in very low birth weight infants in Switzerland. Eur J Pediatr. 2005;164(5):292-297
184. Laughon MM, Langer JC, Bose CL, et al Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. Am J Respir Crit Care Med. 2011;183(12):1715-1722
185. Bassler D, Stoll BJ, Schmidt B, et al Trial of Indomethacin Prophylaxis in Preterms Investigators. Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection. Pediatrics. 2009;123(1):313-318